Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine

NPR

Published

Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide.

Full Article